Roger T. Staff

Efficacy and safety of tau-aggregation inhibitor therapy in patients with mild or moderate Alzheimer's disease: a randomised, controlled, double-blind, parallel-arm, phase 3 trial

Serge Gauthier, Howard Feldman, Lon S. Schneider et al. · The Lancet · 2016 · 416 citations · Full text

Medicine, Neurology, Pharmacology +14

What provides cerebral reserve?

Roger T. Staff, Alison D. Murray, Ian J. Deary et al. · Brain · 2004 · 268 citations

Social Sciences, Neuroscience, Psychology +17

Tau Aggregation Inhibitor Therapy: An Exploratory Phase 2 Study in Mild or Moderate Alzheimer's Disease

Claude M. Wischik, Roger T. Staff, Damon Wischik et al. · Journal of Alzheimer s Disease · 2015 · 258 citations · Full text

Life Sciences, Pharmacology, Pharmacotherapy +17

Potential of Low Dose Leuco-Methylthioninium Bis(Hydromethanesulphonate) (LMTM) Monotherapy for Treatment of Mild Alzheimer’s Disease: Cohort Analysis as Modified Primary Outcome in a Phase III Clinical Trial

Gordon Wilcock, Serge Gauthier, Giovanni B. Frisoni et al. · Journal of Alzheimer s Disease · 2017 · 217 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

Brain White Matter Hyperintensities: Relative Importance of Vascular Risk Factors in Nondemented Elderly People

Alison D. Murray, Roger T. Staff, Susan D. Shenkin et al. · Radiology · 2005 · 203 citations

Medicine, Neurology, Neuroscience +17